June 8 (Reuters) - Merit Medical Systems Inc MMSI.O :
* MERIT MEDICAL ANNOUNCES ACQUISITION OF DIALYSIS CATHETER
PORTFOLIO AND THE BIOSENTRY® BIOPSY TRACT SEALANT SYSTEM FROM
ANGIODYNAMICS, INC. AND ACQUISITION OF THE SURFACER® INSIDE-OUT®
ACCESS CATHETER SYSTEM FROM BLUEGRASS VASCULAR TECHNOLOGIES,
INC.
* MERIT MEDICAL SYSTEMS INC: MERIT RE-AFFIRMS FULL-YEAR 2023
FINANCIAL GUIDANCE ON STAND-ALONE BASIS
* MERIT MEDICAL SYSTEMS INC: UPDATES FULL-YEAR 2023
FINANCIAL
GUIDANCE TO INCLUDE PARTIAL-YEAR IMPACT FROM ACQUISITIONS
* MERIT MEDICAL SYSTEMS : ACQUISITION OF PORTFOLIO OF
DIALYSIS
CATHETER PRODUCTS, BIOSENTRY BIOPSY TRACT SEALANT SYSTEM FOR
$100 MILLION
* MERIT MEDICAL SYSTEMS INC: SEES 2023 NON-GAAP EARNINGS PER
SHARE
$2.81 - $2.92
Source text for Eikon: ID:nGNX8z3K0t
Further company coverage: MMSI.O
((Reuters.Briefs@thomsonreuters.com;))